Jarushka Naidoo, Professor of Medical Oncology at Beaumont RCSI Cancer Centre, shared on X:
“Superb talk at AILCC26 from Stephen Liu on the latest in SCLC:
- BiTEs: Tarla now a SOC in 2L (awaiting Irish approval) and new data due to come out at ESMO26,
- ADCs: B7H3 ADCs showing survival benefit in ph III trials (e.g: Tam-Peli), more to come.”
You might be interested in:
ESMO 2026: 10 ADCs in Lung Cancer to Watch
